DYSPNOEA is the #11 most commonly reported adverse reaction for FINASTERIDE, manufactured by Organon LLC. There are 2,105 FDA adverse event reports linking FINASTERIDE to DYSPNOEA. This represents approximately 2.0% of all 103,583 adverse event reports for this drug.
Patients taking FINASTERIDE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DYSPNOEA2,105 of 103,583 reports
DYSPNOEA is a less commonly reported adverse event for FINASTERIDE, but still significant enough to appear in the safety profile.
Other Side Effects of FINASTERIDE
In addition to dyspnoea, the following adverse reactions have been reported for FINASTERIDE:
DYSPNOEA has been reported as an adverse event in 2,105 FDA reports for FINASTERIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DYSPNOEA with FINASTERIDE?
DYSPNOEA accounts for approximately 2.0% of all adverse event reports for FINASTERIDE, making it a notable side effect.
What should I do if I experience DYSPNOEA while taking FINASTERIDE?
If you experience dyspnoea while taking FINASTERIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.